// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Investigating the pathogenicity of missense mutations in VSX1 and their association with corneal dystrophies

Anastasia Marie Litke - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Management of Restrictive Esotropia Following Pterygium Surgery

Irma Muminovic - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Perceptual eye dominance in human adults quantified using binocular orientation combination

Jiawei Zhou - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

On the relationship between eye dominance and stereopsis: normative data

Yonghua Wang - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Contribution of binocular vision to the performance of a precision manipulation task in 8-14 years old children

Ewa Niechwiej-Szwedo - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Changing Vergence Function in Persons with Parkinson’s Disease and Convergence Insufficiency

Elizabeth L Irving - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

NF-kB-upregulated microRNA (miRNA) in age-related macular degeneration (AMD) and Alzheimer's disease (AD) contribute interactively to altered innate-immunity, amyloidogenesis and inflammatory neurodegeneration

Walter J Lukiw - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Pigment Dispersion Syndrome and Pigmentary Glaucoma Associated Variants in Premelanosome Protein (PMEL) Cause Protein Processing and Fibrillogenesis Defects

Adrian Lahola-Chomiak - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

Atypical cadherin FAT1 is essential for vertebrate optic fissure closure

Aman George - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

Structure and membrane binding of R9AP, a protein involved in phototransduction

Sarah Bernier - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Persistent fetal vasculature in Nrp2 knockout eye

Maryam Hejazi - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

N/A

N/A

A role for the VE-cadherin complex in childhood blinding disorders

Michael Hung Ngo - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Mutations in RP1L1 are Associated with Stargardt Macular Degeneration

Nicole C L Noel - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

Analysis of the promoter and 5’-flanking region of the human serotonin receptor gene HTR2B and its expression in uveal melanoma

Manel BENHASSINE - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Ceritinib is a more potent ALK inhibitor than crizotinib in uveal melanoma

Jade Marie Lasiste - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Crizotinib

The relationship between prognostic factors and CD109 expression in uveal melanoma

Jacqueline Coblentz - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Nestin in uveal melanoma: a novel biomarker

Tadhg Ferrier - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Recruitment and activation of hepatic stellate cells by uveal melanoma cells in a xenograft mouse model

Leo PIQUET - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Co-transplantation of RPE and photoreceptors rescues vision in a mouse model of advanced retinal degeneration

Nikolaos Mitrousis - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hyaluronic acid

Relationship between VEGF and the Kallikrein-Kinin system in a rat model of laser-induced choroidal neovascularization

Olivier Fontaine - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

R954

Copyright © 2026. QuantiNova All rights reserved